Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Chronic obstructive pulmonary disease

Recruiting

Registered drug

Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Tezepelumab

Contact Research Centre

Psychotic disorder+2

Recruiting

Investigational

Study on ITI-1284 for Treating Psychosis in Alzheimer's Patients

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Iti-1284

Contact Research Centre

Colitis ulcerative+1

Recruiting

InvestigationalNo placebo

Study on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting

InvestigationalNo placebo

Study on Long-term Safety and Efficacy of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Riliprubart

Contact Research Centre

Thrombocytopenia

Recruiting

InvestigationalNo placebo

Study on the Effectiveness and Safety of Human Normal Immunoglobulin (IV) for Adults with Chronic Immune Thrombocytopenia

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Human Normal Immunoglobulin (Iv)

Contact Research Centre

Myelodysplastic syndrome

Recruiting

Registered drug

Study on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Plasma cell myeloma refractory

Recruiting

Registered drugNo placebo

Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Registered drug

Study on the Safety and Effects of NSC001 and Trospium Chloride for Patients with Mild to Moderate Alzheimer's Disease

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Hormone-dependent prostate cancer

Recruiting

Registered drugNo placebo

Study on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Anaemia+1

Recruiting

Investigational

Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Elritercept

Contact Research Centre

Chronic lymphocytic leukaemia+1

Recruiting

Registered drugNo placebo

Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Obinutuzumab

Contact Research Centre

Immune thrombocytopenia

Recruiting

Registered drug

Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Find therapies in clinical trials near you – page 9

390 trials match your criteria

Chronic obstructive pulmonary disease

Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Psychotic disorder+2

Study on ITI-1284 for Treating Psychosis in Alzheimer's Patients

Colitis ulcerative+1

Study on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease

Chronic inflammatory demyelinating polyradiculoneuropathy

Study on Long-term Safety and Efficacy of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Thrombocytopenia

Study on the Effectiveness and Safety of Human Normal Immunoglobulin (IV) for Adults with Chronic Immune Thrombocytopenia

Myelodysplastic syndrome

Study on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

Plasma cell myeloma refractory

Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

Dementia Alzheimer's type

Study on the Safety and Effects of NSC001 and Trospium Chloride for Patients with Mild to Moderate Alzheimer's Disease

Hormone-dependent prostate cancer

Study on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer

Anaemia+1

Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

Chronic lymphocytic leukaemia+1

Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Immune thrombocytopenia

Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.